New snakebite treatment makes major advance

October 10, 2017, University of Arizona
Credit: CC0 Public Domain

A University of Arizona researcher developing a therapy to prevent or delay the dangerous results of rattlesnake and other venomous snakebites in humans has shown that a combination of carbon monoxide and iron inhibits snake venom's effects for up to an hour in animals, a major advance in bringing the treatment to market.

Snake venom is hemotoxic—destructive to the ability of to clot—and can cause the destruction of fibrinogen, an essential protein that enables blood to clot and stop excessive bleeding. Snake venom enzymes also can cause abnormally fast clotting, which can lead to heart attack, stroke and damage to the body's organs. Both reactions are inhibited by the therapy.

Vance G. Nielsen, MD, professor and vice chair for research in the UA Department of Anesthesiology at the UA College of Medicine - Tucson, has confirmed that, if given soon enough after a bite, the -iron-based therapy directly can inhibit snake venom's ability to block blood clotting in laboratory animals for as long as an hour. Dr. Nielsen also demonstrated for the first time in the that the therapy blocks 's ability to cause abrupt clotting. The findings recently were published in the journals Basic & Clinical Pharmacology & Toxicology and the Journal of Thrombosis and Thrombolysis.

Time is of the essence following exposure to rattlesnake venom because without fibrinogen, blood does not clot and the risk of internal bleeding increases, resulting in serious health consequences such as blood entering the brain or intestines. In addition, abnormally fast clotting in the blood vessels can deplete clotting factors and cause excessive bleeding or the clots can block blood vessels, causing lethal loss of blood flow to tissue.

Dr. Nielsen has found that the therapy works against the venom of more than three dozen species of snakes throughout the world.

"The excitement is that we have proven that carbon monoxide has the ability to directly inhibit essentially all hemotoxic venom enzymes in the test tube and that it blocks the effects of the Western Diamondback rattlesnake's in animals. The effects on coagulation of some of the deadliest snake venoms in the world—South American, North American and even African, such the cobra's—can be delayed by a treatment that could be delivered with a device much like an EpiPen used for allergic reactions," said Dr. Nielsen, who is working toward developing the treatment to work in humans.

To further advance the research, Dr. Nielsen is seeking commercial backing and is working with Tech Launch Arizona, the UA office that commercializes inventions stemming from university research, to protect the intellectual property of the treatment and strategize ways to get it into the hands of health professionals.

He also is collaborating with toxicologist Leslie Boyer, MD, founding director of the UA VIPER Institute and professor of pathology and pediatrician, who develops antivenom treatments for snakebite and scorpion stings. Dr. Boyer also is a member of the UA BIO5 Institute.

"Our aim is to bring to market a therapy that is safe for humans and animals, has a long shelf life, is readily available and can be stocked in ambulances, or even first-aid kits for campers or hikers, to save lives," said Dr. Nielsen.

Explore further: New snakebite treatment under development at UA College of Medicine - Tucson

More information: Vance G. Nielsen et al, Characterization of the Rabbit as an In Vitro and In Vivo Model to Assess the Effects of Fibrinogenolytic Activity of Snake Venom on Coagulation, Basic & Clinical Pharmacology & Toxicology (2017). DOI: 10.1111/bcpt.12848

Vance G. Nielsen. Effects of purified human fibrinogen modified with carbon monoxide and iron on coagulation in rabbits injected with Crotalus atrox venom, Journal of Thrombosis and Thrombolysis (2017). DOI: 10.1007/s11239-017-1549-2

Related Stories

New snakebite treatment under development at UA College of Medicine - Tucson

April 14, 2016
Time is of the essence for treating venomous snakebites, and a product being developed by University of Arizona College of Medicine - Tucson researchers may extend that window for treatment.

New insights may help protect against snake venom toxicity

April 20, 2017
New research may be useful for protecting against the toxic effects of snake venom.

Recommended for you

Whether sustained or sporadic, exercise offers same reductions in death risk

March 22, 2018
For decades, Americans have been inundated with a confusing barrage of messages about how best to counteract the health risks of sedentary lifestyles: walk 10,000 steps a day; do a seven-minute workout from a phone app; flip ...

Tai chi as good as or better than aerobic exercise for managing chronic pain

March 21, 2018
The ancient martial art of tai chi has similar or greater benefits than aerobic exercise for people with the chronic pain condition fibromyalgia, finds a trial published by The BMJ today.

Study: Poor health is a less common cause of bankruptcy than commonly thought, but it brings other economic woes

March 21, 2018
A team of researchers led by an MIT economist has found that medical expenses account for roughly 4 percent of bankruptcy filings among nonelderly adults in the U.S.

Study finds bad sleep habits start early in school-age children

March 21, 2018
Bad sleep habits in children begin earlier than many experts assume. That's the takeaway from a new study led by McGill University researchers. The findings suggest that official sleep guidelines for young school children ...

Medical expansion has improved health—with one exception

March 21, 2018
While Americans debate the rising cost of health care, a new study of 30 countries over 27 years found that medical expansion has improved overall health - with one major exception.

Forgetting details, getting the gist may prompt false memories in older adults

March 21, 2018
Older adults often complain about forgetting, but Penn State psychologists suggest that another problem may be misremembering.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.